Pharmalittle: We’re reading about Novo licensing a Chinese obesity pill, Merck pulling an antibiotic, and more Roche stopped work on an obesity drug candidate after trial data fell short

https://www.statnews.com/pharmalot/2026/09/29/novo-licenses-obesity-pill-from-china-merck-pulls-antibiotic/ By Ed SilvermanSept. 29, 2026 Pharmalot Columnist, Senior Writer